MedEdTalks - Neurology podcast

Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle

0:00
15:56
Rewind 15 seconds
Fast Forward 15 seconds

In this podcast, expert clinicians will revisit an important topic from MS Forum® VIII, the use of current and emerging oral therapies for MS, including the Burton's tyrosine kinase (BTK) inhibitors.

More episodes from "MedEdTalks - Neurology"